These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3802851)

  • 1. Using baseline measurements in the two-period crossover clinical trial.
    Willan AR; Pater JL
    Control Clin Trials; 1986 Dec; 7(4):282-9. PubMed ID: 3802851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the maximum test statistic in the two-period crossover clinical trial.
    Willan AR
    Biometrics; 1988 Mar; 44(1):211-8. PubMed ID: 3358989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian analysis of the two-period crossover design for clinical trials.
    Grieve AP
    Biometrics; 1985 Dec; 41(4):979-90. PubMed ID: 3830262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critique of recent research on the two-treatment crossover design.
    Fleiss JL
    Control Clin Trials; 1989 Sep; 10(3):237-43. PubMed ID: 2676339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal crossover designs in the presence of carryover effects.
    Laska E; Meisner M; Kushner HB
    Biometrics; 1983 Dec; 39(4):1087-91. PubMed ID: 6671121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple method for the estimation of interaction bias in crossover studies.
    Cleophas TJ
    J Clin Pharmacol; 1990 Nov; 30(11):1036-40. PubMed ID: 2243151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carryover and the two-period crossover clinical trial.
    Willan AR; Pater JL
    Biometrics; 1986 Sep; 42(3):593-9. PubMed ID: 3567292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the crossover design in the presence of residual effects.
    Lehmacher W
    Stat Med; 1991 Jun; 10(6):891-9. PubMed ID: 1876779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of two-treatment, two-period crossover trials in emergency medicine.
    Reed JF
    Ann Emerg Med; 2004 Jan; 43(1):54-8. PubMed ID: 14707941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal and efficient crossover designs under different assumptions about the carryover effects.
    Hedayat AS; Stufken J
    J Biopharm Stat; 2003 Aug; 13(3):519-28. PubMed ID: 12921398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-period crossover design for the comparison of two active treatments and placebo.
    Koch GG; Amara IA; Brown BW; Colton T; Gillings DB
    Stat Med; 1989 Apr; 8(4):487-504. PubMed ID: 2657956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The performance of the two-stage analysis of two-treatment, two-period crossover trials.
    Freeman PR
    Stat Med; 1989 Dec; 8(12):1421-32. PubMed ID: 2616932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crossover trials with a binary response: a powerful method despite the carryover effect.
    Cleophas TJ; van Lier HJ
    J Clin Pharmacol; 1996 Mar; 36(3):198-202. PubMed ID: 8690812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of alternative statistical models for crossover studies to demonstrate caffeine adjuvancy in the treatment of tension headache.
    Koch GG; Amara IA; MacMillan J
    J Biopharm Stat; 1994 Nov; 4(3):347-410. PubMed ID: 7881452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal and/or Efficient Two treatment Crossover Designs for Five Carryover Models.
    Gondaliya J; Divecha J
    Int J Biostat; 2018 Nov; 14(2):. PubMed ID: 30471221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-period crossover designs for two treatments.
    Ebbutt AF
    Biometrics; 1984 Mar; 40(1):219-24. PubMed ID: 6733230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The two-period crossover design in medical research.
    Woods JR; Williams JG; Tavel M
    Ann Intern Med; 1989 Apr; 110(7):560-6. PubMed ID: 2923388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A note on the sample size determination in two-period repeated measurements crossover design with application to clinical trials.
    Yue LQ; Roach P
    J Biopharm Stat; 1998 Nov; 8(4):577-84. PubMed ID: 9855035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the effects of lithium in the treatment of chronic alcoholism. II. Assessment of the two-period crossover design.
    Peck CC; Pond SM; Becker CE; Lee K
    Alcohol Clin Exp Res; 1981; 5(2):252-5. PubMed ID: 7018306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Handling of baseline measurements in the analysis of crossover trials.
    Chen X; Meng Z; Zhang J
    Stat Med; 2012 Jul; 31(17):1791-803. PubMed ID: 22715129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.